We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Genetic Study Identifies Developmental Disorders in Children

By LabMedica International staff writers
Posted on 10 Feb 2017
The largest ever genetic study of children with previously undiagnosed rare developmental disorders has discovered 14 new developmental disorders. More...
The study also provided diagnoses of rare conditions for over a thousand children and their families.

There are over 1,000 recognized genetic causes, however many individual developmental disorders are so rare that the genetic causes are not known. Each year, thousands of babies are born who do not develop normally because of errors in their genetic makeup and this can lead to conditions such as intellectual disability, epilepsy, autism or heart defects.

A large team of scientists collaborating with the Wellcome Trust Sanger Institute sequenced the exomes of 4,293 families containing individuals with developmental disorders, and meta-analyzed these data with data from another 3,287 individuals with similar disorders. The team focused on spontaneous new mutations that arise as DNA is passed on from parents to children. The children's conditions were also clinically assessed and the team combined the results to match up children with similar disorders to provide diagnoses.

Saliva samples for the whole family and blood-extracted DNA samples for the probands were collected, processed and quality controlled. Genomic DNA was fragmented to an average size of 150 base pairs (bp) and a DNA library was created using established Illumina paired-end protocols. Adaptor-ligated libraries were amplified and indexed using polymerase chain reaction (PCR). A portion of each library was used to create an equimolar pool comprising eight indexed libraries. Enriched libraries were analyzed by 75-base paired-end sequencing.

The scientists showed that how that the most important factors influencing the diagnostic yield of damaging de novo mutations (DNMs) are the sex of the affected individual, the relatedness of their parents, whether close relatives are affected and the parental ages. They identified 94 genes enriched in damaging DNMs, including 14 that previously lacked compelling evidence of involvement in developmental disorders. They have also characterized the phenotypic diversity among these disorders. They estimated that 42% of their cohort carries pathogenic DNMs in coding sequences; approximately half of these DNMs disrupt gene function and the remainder result in altered protein function.

Jeremy McRae, PhD, the first author of the study, said, “Each of these disorders is incredibly rare, so the large number of patients in this study was crucial to diagnosis. An individual doctor may see only one case, but by collaborating with hundreds of NHS staff and researchers we were able to link children from clinics across the British Isles. This allowed the team to match up children with similar disorders within the project and provide diagnoses for them.” The study was published on January 25, 2017, in the journal Nature.


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.